Trials / Completed
CompletedNCT04027283
Acute Effects of the Two Alternative Sweeteners D-allulose and Erythritol on Metabolism
Acute Effects of the Two Alternative Sweeteners D-allulose and Erythritol on Gastrointestinal Hormone Secretion and Glycemic Control
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The aim of this project is to investigate the effect of intragastric (ig) D-allulose on metabolic parameters in general and to investigate the effect of sweet taste receptor blockade on GI hormone responses, glycemic control, gastric emptying (GE) rates and appetite-related sensations to ig administration of erythritol and D-allulose.
Detailed description
Erythritol (natural non-caloric sweetener) could be an ideal candidate substitute for sugar as it may reduce caloric intake without compensatory overeating or earlier return of hunger. Moreover, it may serve as a physiological tool to disentangle the effects of gastrointestinal (GI) sweet taste receptor stimulation, (an)orexigenic hormone secretion, and glucose metabolism/caloric content on food intake regulation in vivo in humans. However, its effects on appetite, satiation, and satiety have not been studied systematically. Moreover, the mechanisms underlying erythritol-induced anorexigenic GI hormone release have not been investigated so far. D-allulose is a sugar substitute with almost zero calories and is naturally occurring in small quantities. Apart from its use as sugar replacement, D-allulose seems to favorably affect glycemic control and metabolism as could be shown in animal trials and in a few human trials. However, to date the effects of D-allulose on GI hormone secretion, appetite-related sensations and glycemic control, are not or insufficiently studied in humans. The aim of this project is therefore to investigate the effect of intragastric (ig) D-allulose on metabolic parameters in general and to investigate the effect of sweet taste receptor blockade on GI hormone responses, glycemic control, gastric emptying (GE) rates and appetite-related sensations to ig administration of erythritol and D-allulose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Erythritol | 50g erythritol dissolved in 300mL tap water |
| DIETARY_SUPPLEMENT | Erythritol + lactisole | 50g erythritol + lactisole (450ppm) dissolved in 300mL tap water |
| DIETARY_SUPPLEMENT | D-allulose | 25g D-allulose dissolved in 300mL tap water |
| DIETARY_SUPPLEMENT | D-allulose + lactisole | 25g D-allulose + lactisole (450ppm) dissolved in 300mL tap water |
| DIETARY_SUPPLEMENT | Tap water | 300mL tap water |
| DIETARY_SUPPLEMENT | Tap water + lactisole | 300mL tap water + lactisole (450ppm) |
Timeline
- Start date
- 2019-09-01
- Primary completion
- 2020-09-01
- Completion
- 2020-09-01
- First posted
- 2019-07-19
- Last updated
- 2020-09-29
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04027283. Inclusion in this directory is not an endorsement.